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ABSTRACT
We have determined the exon structure of the mouse
tyrosinase-related protein-1 (TRP-1) gene. The gene is
only 15kb in length, but contains seven introns, in
contrast to the tyrosinase gene which is almost 1 00kb
long with only four introns. Only two introns are located
in homologous positions in both genes. Intron I of
TRP-1 has three alternative 5' splice sites clustered
within 21 bp, which all splice to the same 3' site. Intron
V has a very unusual 5' splice site, which has the
dinucleotide GC rather than the conventional GT. We
show that as little as 370bp of 5'-flanking DNA is
sufficient to direct cell-specific expression of the
chloramphenicol acetyl transferase gene. The flanking
DNA of TRP-1, unlike tyrosinase, does not contain a
TATA box or a CCAAT box. Both mouse genes,
however, share an 11bp sequence, also found in
human tyrosinase, which we suggest may be a
melanocyte-specific promoter element.
INTRODUCTION
Synthesis of melanin by melanocytes requires a number of
enzymes (1). Key among these is tyrosinase, which catalyses the
conversion of tyrosine to dihydroxyphenylalanine (DOPA) and
DOPA to dopaquinone (2). A number of other enzyme functions
have been identified, such as dopachrome tautomerase and
dihydroxyindole reductase, which are probably not essential for
pigmentation but which accelerate reactions thought to occur
spontaneously (2-5).
Tyrosinase cDNA has been cloned, both from mouse and
human (6-9). It maps in the mouse to the albino locus on
chromosome 7 (10), and specific mutations have been identified
in mouse and human albino individuals (11-19). A second
cDNA has been isolated which encodes a protein clearly related
to tyrosinase, with about 52% amino acid identity (20). This gene,
called tyrosinase related protein -1 (TRP-1), maps to the murine
brown locus on chromosome 4 (21). Null mutations in this gene
result in the production of brown rather than black eumelanin
(22, 23). A third member of this gene family, TRP-2, has been
identified and it encodes a protein equally related to the other
two (21 and UJ, unpublished).
The mouse and human tyrosinase genes have been cloned, their
intron structure determined, the end of their transcripts mapped,
and the regulatory regions 5' of the transcription units sequenced
and analysed (24-29). We have performed a similar analysis
EMBL accession no. X59513
on the mouse TRP-1 gene. Based on the clear evolutionary
relationship between the two genes we expected to find strong
similarities between the gene structures. However, we have found
that TRP-1 has seven introns, compared to four in tyrosinase,
only two of which are in conserved positions in the two genes.
One of these introns in TRP-1 has a highly unusual 5' splice site,
which nevertheless is used accurately. Although the 5' end of
the tyrosinase gene contains a number of recognised cis-acting
regulatory elements, including TATA boxes, CCAAT boxes and
several palindomic and direct repeat sequences, no such elements
are present in a region of several hundred bases pairs which flanks
the TRP-1 transcriptional start site, despite the fact that this region
of DNA is sufficient to specifically direct synthesis of
chloramphenicol acetyl transferase (CAT) in melanoma cells. We
identify an 1 lbp sequence which is found between 40 and 140
upstream of the multiple transcriptional start sites of TRP-1 and
about 90 and 140bp upstream of the major transcriptional start
sites of mouse and human tyrosinase respectively, which we
suggest may be a melanocyte specific cis-acting element.
MATERIALS AND METHODS
Library screening, clone isolation, subcloning and sequencing
The bacteriophage EMBL3, partial Sau3A library of mouse strain
129 genomic DNA was a gift from Lisa Stubbs (ICRF, London).
The library was screened by plating 2.6 x105 pfu on E. coli
strain Q358 at a density of about 160 pfu/cm2 . Replicas of the
plate were made by overlaying with nylon membrane (Hybond-
N; Amersham) and fixed by UV irradiation and baking. The
filters were hybridised in 0.5M sodium phosphate, pH 7.2, 7%
SDS (30) with fragments of the TRP-1 cDNA, pMT4 (20),
labelled with 32p using DNA polymerase I in a random-primed
labelling kit (31)(Boehringer-Mannheim). Positive phage were
picked and rescreened to single plaques. DNA was purified from
the phage, restriction mapped with a number of enzymes, and
suitable fragments subcloned into pBluescribe (Stratagene). Exon
and intron/exon junction sequences were obtained using
Sequenase kits (USB) on double-stranded DNA with primers
flanking the polylinker (as supplied), or primers as described
below.
Oligonucleotide primers
All oligonucleotides were synthesised on ABI 381A or 391 DNA
synthesisers, deprotected overnight at 65°C in 30% ammonium
hydroxide and precipitated from 0.3M sodium acetate with 70%
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ethanol. Primers for sequencing the exons were designed from
the published cDNA sequence, as previously described (20, 22).
Further primers were made according to sequences determined
5' of the gene and within intron I to allow confirmation and
extension of sequences.
Polymerase chain reaction
Alternative splice sites were analysed in cDNA from total RNA
prepared from neonatal mouse skin as described. The polymerase
chain reaction was performed using primers CAATTAACAG-
CTGGCATC (bases -174 to -157) and TCTCGTGGAAAC-
TGAGCC (complement of bases 85 to 68) as described previously
(22, 32), denaturing initially at 94°C for 2 minutes, followed
by 30 cycles of 94°C for 15 seconds, 55°C for 15 seconds and
72°C for 30 seconds. The products were analysed on 4% Nuseive
agarose gels, isolated from the gel using Geneclean (BIO 101,
La Jolla, CA), and sequenced directly with the amplifying primers
in 10% DMSO according to the method of Winship (33).
Primer extension
The 5' ends of the transcripts were determined by extension of
an oligonucleotide primer GGAAGGTTTCTCTGCTGA,
covering bases -97 to -114 of exon 1, using RNA prepared
from B16 melanoma cells. The primer was 5'-end labelled with
32p and purified after electrophoresis in polyacrylamide/urea
gel. 16,000 cpm were annealled to 20ig total RNA at 70°C and
cooled to room temperature. The primer was extended with AMV
reverse transcriptase in lOmM Tris, 1OmM MgCl2, 1mM DTT,
lmM deoxynucleotide triphosphates for 1 hour at 42°C. The
products were analysed by electrophoresis on 6%
polyacrylamide/urea gels and visualised by autoradiography.
Melanoma cell culture and CAT assay
Fragments from the 5' end of the TRP-1 gene were cloned into
the chloramphenicol acetyl transferase (CAT) expression vector
pBLCAT3 (34). Both fragments terminated at their 3' end at the
PvuII site at base - 164, and at the 5' end at either the HindIl
site at -642, or the XbaI site at approximately -1600. B16
melanoma cells were normally maintained in MOPS-L medium,
which consists of HAMS FIO medium supplemented with
glutamine buffered by 187 mM MOPS and 84 mM NaHCO3.
This gives a slightly acidic pH which minimises pigment
production. Following transfection the cells were transferred to
DMEM, which has a slightly alkaline pH and stimulates melanin
synthesis. Cells were grown in a 5% CO2 atmosphere. DNA
constructs were introduced into cells using lipofectin (BRL,
Gaithersburg, MD) according to the manufacturer's instructions,
the DNA was allowed to express for 48 hrs and the cells
harvested. The CAT reaction was assayed as described using
'4C-acetyl CoA (35); the products being separated by thin-layer
chromatography, autoradiographed, and quantitated by scraping
the spots and liquid scintillation counting.
hybridisation to the cDNA was restricted to about 1.5 kb. We
believe that these clones represent a second locus, previously
described (21), which maps apart from TRP-1, and which is
probably a processed pseudogene. The remaining 4 clones form
an overlapping set, spanning about 38 kb of mouse DNA.
Restriction mapping, subcloning of fragments, sequencing of
exons using specific oligonucleotides and PCR between
oligonucleotides on neighbouring exons has allowed us to derive
the map of the TRP-l gene in Figure 1. The gene is divided into
eight exons. The first exon is entirely 5' non-coding sequence,
the second is 5' non-coding and protein coding and the eighth
is both coding and 3' non-coding. All the introns are fairly small,
ranging from 0.55 to 2.75kb, and the exons are fairly uniform
in length; with the exception of the final, lkb exon, they range
between 147 and 470 bp. The overall length of the TRP-1
transcription unit is thus less than 15kb. Table I summarizes these
sizes.
We have sequenced the whole of intron I, and 5' flanking DNA
extending for several hundred base pairs 5' of the gene. Figure 2
shows this sequence, on which is marked the transcriptional start
sites, and the alternative splice sites of intron I (see below). We
have identified, by search of the sequence databases, a highly
diverged B2 repeat element in this intron, between approximately
bases 755 and 925 (Figure 2). The B2 sequence has equal
similarity (65-70%) with both the rat and mouse repeats and
may represent an ancestral member of this family.
Splicing of the TRP-1 transcript
When we sequenced a new TRP- 1 cDNA clone we found an
apparent insertion of 6 base pairs at the exons 1 and 2 boundary,
when compared to the sequence from Shibahara et al (20).
Table 1. Size and locations of introns and exons. Numbering is according to
Shibahara et al. The 4 transcriptional starts and 3 alternative splices results in
potentially 12 different first exons, these are shown in Figure 1.
exon size (bp) position intron size (kb)
1 87 to 208 see Fig 1 I 0.57 to 0.59
2 470 -85 to +385 II 2.0
3 323 386-708 III 2.75
4 205 709-913 IV 1.6
5 168 914-1081 V 1.7
6 180 1082-1261 VI 2.45
7 147 1262-1408 VII 0.8
8 1041 1409-2449
- lkb
E
4tVti
2
E E
3 I 5I a
,, * III * IV 0
1 4 S 6
E
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RESULTS
Isolation and gene structure of the TRP-1 gene
A library of mouse DNA, from strain 129, cloned into EMBL4
was screened with probes from the TRP-1 cDNA, pMT4. Six
strongly hybridising phage were identified and isolated.
Restriction mapping and hybridisation to specific oligonucleotides
showed that these fell into two classes. Two clones did not
hybridise well to any oligonucleotide, and the region of
.4 X1.0-1
XI.6-6 -
Figure 1. The structure of the TRP-l gene. Exons are numbered I to 8 (Arabic),
and introns I to VII (Roman). Open boxes represent 5' and 3' untranslated regions
of the mRNA, filled boxes are the protein-encoding regions and the line is flanking
and intronic DNA. Below the gene are shown three X recombinant clones, from
which the gene structure was determined. E = EcoRI sites.
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Inspection of the genomic sequence in this region shows that these
six bases were derived from the 5' end of intron I, by use of
a second consensus splice site. To further examine splicing of
intron I we used the polymerase chain reaction to amplify cDNA
fragments spanning the junction of exons 1 and 2. High resolution
agarose gels reveal at least 3 amplification products which were
isolated and sequenced directly. Three alternative 5' splice sites
were found; the one resulting in the cDNA described by
Shibahara et al, one 6bp 3' of this, as found in our cDNA and
a third a further 15bp downstream. The sites are shown in
Figure 2 as IA, IB and IC. All three conform to the 5' splice
concensus sequence (see Table 2) and all are joined to the same
3' site. The three PCR products were of approximately equal
abundance suggesting that all three sites are used approximately
equally.
Table 2 lists the sequences at the nine 5' and seven 3' sites
of all seven introns. The exact splice site, where any ambiguity
exists, has been placed so that the sequences conform to the
established consensus, which is that introns invariably begin with
the dinucleotide GT and end with AG (but see below); coupled
with a comparison to the cDNA sequence, this has allowed exact
1 AAGCTTTGTAGAGTAATCATGTATTCCAAACTCAGGCTTACATTTGAATGTTGGCTACAT
61 ATGTATGAGTTTTCAACTTCCAGGAGAAAACGTCTCTTTAAAAGAGAACAACCAAAAGCT
121
181
AACAGAAAATACAAGTGTGACATTGGCCTTAGTTCGACCAAGAAAGCAATTCATCTTGTT
TCTTCCTTTGTGGTATACAGATAAGAAAAATAAAATCACTACAACGAAAGCAAAATCTCT
241 TCAGCGTCTCTAATACATCTTCCAAATCAGTGTGTCTGACCTTTTCTTAAGACTTTAACC
301
361
421
481
541
ATCACAAGGAAACCAGTGGGGAGG ACTGTGTAGTAGTTAAAGGGCAGGAGA
ATTCACTGGTGTGAGAAGGGATTAGTGAGAGCTGGAAGAGAGGACCAGCCCCTCCCAGTG
74
TGAGGAATCTGGCTTGGGATTTACTGTCTGGCAGAAAATCTCTTCGGGCAATTAACAGCT
GGCATCAGGGGAAAAGCAGACATCCAACAACACTAGCTCTGAAGGAGATCAGCAGAGAAA
,LIA aJIB ,IC
CCTTCCAGGGATTCATGGTACTGGTGAGCAGCTCTGTGGTGGGTACCCTTGTGACCAAAG
601 CTCTAGGAACATGAAGGAGATTTGCTTGCTATAAACCTGTTTCCTATTCTCCTTTCATTT
661 CCATGGTTAACTATTACTATGGTAGTCACCAACTAGTGGATGCTTTTGGTAAATGACATC
721
781
TATGGAAAGTCTTTTTGGATCAGGGTGATCTTTTTATGTATGTGTATGTGCATGGATATG
GGTGCACGAGAGCAGGTGCCCAGATTCTCAAGGAGGGCTTCAGTTACAAGGAGTTGGGAG
841 TGATCTGATGTGGTTGCAAGGCACTGAAGTCAGTCTCTCTGTAAGAGCACTCTATGCTCC
901 TTACCACTGTGCCTTCTCCCCAGCCCAAGAATAGTATTCTTATGGGTAGAAATTTAAATA
961 AGAAACTCAAAGACCAGGAGAGTGAGTTCTGTCATCTAGCTATTATGCCTGCAGATATTT
1021 AAAGGTGAATAATTATTTTGACTATTGTTTAGAAATGTTGTTTCACATGAAAGATTCCAT
1081 TTCCGGAGTGGGTTGAAAAGTATGCAAAAGAACTTTTGCAACTCTGTTTTTGCCTTTCTG
'.I
1141 TTTTTCAGCTGTATTTTCATCTGAGCACCCCTGTCTTCTCCATGCAAAGAGCAGCATAGG
1201 AGACCTGTGTTCTGAACTCTTGCTTCGAGAAGAATG 1236
60
120
180
240
300
positioning of all the introns. Intron V is an example of a very
rare exception to the rule, in which the 5' GT is replaced by
GC. Other than these strongly conserved dinucleotide pairs, splice
sites generally have a loose consensus (36-38). At the 5' end,
there is an A or C at -3 in 69% of cases examined, at -2 is
A in 60% of sites, and at -l is G (79%). The 3' consensus
consists of runs of pyrimidines in the 10 to 12 bases before the
conserved AG. All the TRP-1 splice sites conform to these
patterns.
The TRP-1 Promoter
We have determined the 5' end of the TRP-1 transcripts by
extension of an oligonucleotide primer using reverse transcriptase
on RNA from melanoma cells. Figure 3 shows the result of such
an assay. At least 4 specific fragments are consistently observed,
extending the primer by 56, 57, 153 and 157 nucleotides. This
is consistent with 5' ends at -172, -173, -269 and -273,
Table 2. Sequences surrounding the 5' and 3' splice sites of the 7 TRP-l introns,
including the 3 alternative 5' splices of intron I.
Intron 5' splice 3' splice
IA ATTCATG/GTACTGGT.
IB GGTACTG/GTGAGCAG.
IC CTCTGTG/GTGGGTAC...... CTGTTTTTCAG/CTGTA
II CTCACAG/GTGAGTAG ..........CATGTTTAAAG/TCAGG
III CATGCAG/GTATGCTG ..........CTATGATCTAG/GAGAT
IV TGTAACA/GTAAGACC..... .....TTCCTCCCCAG/GCACT
V GTGGAAG/GCAAGTAA..... .....TTCAAATGTAG/GTTAC
VI AACGCCG/GTGAGATC..... .....GAATATTTTAG/ATATT
VII TGGCCAG/GTCGGTTT ..........CTTTCAAATAG/GTCAG
360
420
480
540
600
660
720
780
840
900
960
1020
1080
'-
-_5
_I
tub
1140
1200 - 1173
q 72-
Figure 2. The sequence of the 5' flanking DNA, the first exon, first intron and
exon 2 up to the translational initiation codon. Exon sequences are underlined.
Splice sites are shown by vertical arrows and transcriptional initiation sites by
bent arrows, but note our data do not allow precise nucleotide assignment of the
initiation sites. The 1 I mer motif shared by TRP-1 and tyrosinase is boxed. The
sequence is deposited in the EMBL sequence database with accession number
X595 13.
Figure 3. Oligonucleotide primer extension to determine the 5' ends of the TRP-1
transcripts. The four extended products are labelled according to the positions
of their initiation. The adjacent sequence ladder is determined using the same
oligonucleotide to prime a sequence reaction.
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Figure 4. Assays of CAT expression of constructs in B16 melanoma cells. The
autoradiograph of thin-layer chromatography shows control (non4transfected) cells,
and cells transfected with pBLCAT3 alone (0), pBLCAT3 plus TRP-1I DNA to
the Xbal site (-1580) and with TRP-1 DNA to the HindIII site (-640). The
line figure shows a schematised view of the constructs, and the relative expression
of CAT from each.
although it is not possible to assign the ends to specific nucleotides
given the fairly broad bands seen on the gel. (When referring
to positions 5' in the sequence we use the numbering of Shibahara
et al (20), in which the base before the translational initiation
codon is - 1, and the smallest spliced form is used). Sizing of
the fragments is by allignment with a sequencing ladder obtained
using the same primer on a subclone of the region and run in
adjacent tracks in Figure 3.
In Figure 2 we show the sequence of the DNA flanking the
TRP-l gene, indicating these 4 start sites, and extending to the
Hind]IIl site at -643. In this region there are no good matches
to any described consensus cis-acting sequences, in particular
there are no TATA or CCAAT boxes. The absence of a TATA
box and thus lack of a TFIID binding site is consistent with the
heterogenous 5' ends of TRP-1 mRNA.
To ensure that these 5' sequences nevertheless were able to
direct specific transcription of the TRP-lI gene, we placed them
upstream of the CAT gene in the vector pBLCAT3 (34), and
introduced the constructs into melanoma and other cells. Figure 4
is the result of CAT activity assays on B16 melanoma cells
transiently transfected with DNA from various CAT constructs.
The promoterless vector alone has measurable but very low
activity in the assay. When approximately 1300bp of DNA 5'
of TRP-1, up to the XbaI site, are ligated upstream of a CAT
gene, a 30-fold increase in activity is seen after transfection.
When a smaller piece of DNA is used, to the HindlIl site (the
sequence in Figure 2), a greater transcriptional activity is
consistently seen. Removing the - 700 bp between the XbaI and
HindIII sites results in a further 3-fold increase in CAT activity,
suggesting the presence of a negative transcriptional element in
this interval. The same short construct, introduced into mouse
TRP-I
I11 III V v VI VIl
SSt Cys-ricih Cu| Cys-rich Cu
tyrosinase I I II Iv
Figure 5. Schematic representation of the protein domains of tyrosinase and
TRP-1. SS = signal sequence; Cys-rich = cysteine-rich domains; Cu = putative
copper-binding sites; t.m. = putative transmembrane region. The arrows indicate
the positions of introns I to VII of TRP-1 and I to IV of tyrosinase. Introns V
and II and VII and IV are in conserved positions in the two genes, as shown.
L-cells or NIH 3T3 cells gave only between 1.5 and 5.5% CAT
expression as compared to its activity in B16 cells (data not
shown); indicating the melanoma specificity of this promoter
element.
DISCUSSION
An unusual 5' splice site
Whilst most of the bases which make up the consensus sequences
determining the position of an RNA splice are not individually
essential, the dinucleotide GT at the 5' end and AG at the 3'
end of the intron are almost invariant. Shapiro and coworkers
have extracted splice sites from the sequence databases and
compiled updated consensuses and they describe a number of
splice sequences which do not match the GT-AG rule (37,38).
Many of these can be eliminated as errors of data entry or
interpretation (see 55 for a discussion). Virtually all of the
remaining non-GT 5' sites, like TRP-1 intron V, have GT
replaced by GC. Aebi et al (39) demonstrated, by assaying for
splice site function in vitro, that the only alternative to GT which
would direct an accurate splice was GC, although the reaction
proceeded more slowly.
If this intron in TRP-1 pre-mRNA is removed at a slower rate,
it nevertheless does not seem to affect the fidelty of splicing.
Primers spanning potential alternative splices in the PCR on
neonatal skin cDNA should permit any such variants to be
detected, but none are (data not shown). Any alternative splices
affected by the unusual intron V 5' end must be very rare, if
they exist at all, to escape detection in this sensitive assay.
TRP-1 gene structure is very different from tyrosinase
The strong sequence similarity between TRP-1 and tyrosinase
indicates a common evolutionary ancestor. We have compared
the positions of introns in the TRP-1 gene, with their positions
in the tyrosinase gene. The sequence similarity between the two
proteins is such that intron locations can be assigned
unequivocally to particular homologous codons. The TRP-1 gene
has an intron in the 5' untranslated region, which tyrosinase does
not. Within the protein coding sequence, TRP-l has 6 introns
and tyrosinase has 4, but only 2 of these are present in
homologous positions: introns V and VII of TRP-1 and introns
II and IV of tyrosinase. Both pairs are in codons which can be
unequivocally identified as homologous, and both are in the same
positions within the codon. The unusual GC 5' splice site is in
TRP-1 intron V, although the homologous tyrosinase intron II
has a conventional GT site.
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The tyrosinase-related family of proteins have five recognisable
protein domians (1); two copper-binding sites with similarity to
sites in lower eukaryote and prokaryote tyrosinases (1, 7, 40,
41), two cysteine-rich domains of unknown function, and a
transmembrane domain by which the enzymes are anchored to
the inner face of the melanosomal membrane. Figure 5 illustrates
these domains, and indicates the locations of the introns in
tyrosinase and TRP-1. Most models of gene evolution have been
based on the idea that exons are the basic evolutionary unit, and
exon shuffling produces a diversity of multi-exon genes. An exon,
in this model, is or was at one time capable of encoding a discrete
protein domain. There are, however, only very few clear
examples where exons are reused in different contexts.
Whilst the introns of tyrosinase and TRP-1 do separate protein
domains, we need to explain why most of the introns are in
different locations in the two genes. The usual assumption is that
a new gene becomes assembled from a set of exons, which may
later be duplicated and introns are gradually lost at random in
the two related genes. This may be true of the evolution of the
tyrosinase/TRP-1 family, although it predicts that some of the
ancestral exons were be rather small, including one encoding a
domain of only 18 and one of only 11 amino acids. Whilst such
small exons could have existed it is worth considering alternatives.
One alternative is that introns have been gained in evolution
as well as lost. The view put forward compellingly by Cavalier-
Smith (42) is that introns were introduced into most eukaryotic
genomes very early in their evolution, about 1000 million years
ago, as self-splicing retroposons which degenerated following
the evolution of spliceosomal processing. The suggestion is that
insertion occurred over a period of several hundreds of millions
of years. Much of the evidence accumulated over recent years
which makes such a model compelling has been reviewed by
Rogers. (43 -46). When genes encoding the same protein
(orthologous genes) are compared between vertebrate species
introns are almost always found in the same positions. However,
when orthologous genes from invertebrates, such as Drosophila,
and vertebrates are compared they frequently have different intron
locations (47). Comparison can also be made within genes where
there has been an internal duplication to result in two related
halves. In many such cases, for example the mdr-J gene (48),
the intron positions in the two halves are different.
Genes that have diverged to encode different but related
proteins, such as tyrosinase and TRP-l (paralagous genes) also
often show different but close intron locations (for example, 49,
50). Intron insertion must be invoked to explain the evolution
of these genes; otherwise in some cases the ancestral exons would
be of only a few base-pairs in length. What explanation can be
offered for the finding, as in this study, that non-homologous
introns do nevertheless tend to occur in similar regions of
homologous genes? In general it is also found that protein
encoding exons have a fairly narrow size distribution (51). We
suggest that selection for splicable transcripts may in part be the
cause. If the RNA splicing machinery requires particular
secondary structure folding, in addition to the concensus splice
sites small exons might be disfavoured and lost in evolution. The
present-day eukaryotic gene structures are the outcome of large-
scale random intron insertion followed by selection.
Promoter sequences of TRP-1 and tyrosinase
Mouse and human tyrosinase genes have both CCAAT and
TATA boxes (25, 26, 29). The former sequence is a core element
capable of binding a number of transcription factors. The TATA
box is normally found, as in these two genes, within 25-40 bp
5' of transcriptional initiation and binds TFIID which directs
accurate initiation. Most tissue-specific genes contain these cis-
acting elements. However, although the murine TRP-1 gene
promoter does have the sequence motif TATA, it is more than
180 bp upstream of transcriptional initiation and cannot be
functioning as a TFIID binding site. The heterogenous 5' ends
of the transcipt bear this out. Nor is there is a CCAAT element
upstream of TRP-1, but on the opposite strand there is the core
of the NF-1 binding site (GCCAAT seen as ATTGGC at bases
142-148 in Figure 2). This 'inverted' CCAAT box has a 7/12
match to the core of the Y-box element (CTGATTGGCCAA)
found upstream of both some ubiquitous and some tissue specific
genes (52, 53). There are no binding sites for transcription factors
Spi, CREB, AP-1, AP-2, Oct-I or 2, C/EBP COUP/TF or SRF.
The tyrosinase and TRP-1 genes not only show common
ancestry, they are also similarly regulated; both are melanocyte-
specific transcripts (7, 20, 24). The lack of obvious similarity
between the promoter regions is thus puzzling. If the
5'-untranslated exon has been acquired by TRP-1 during its
evolution some of the regulatory sequences may now be located
in the first intron; which therefore might have enhancer function.
Searching of the intron sequence does not identify any
characterised transcription factor binding sites. Furthermore, as
the 370-470bp 5' of the gene alone are sufficient to direct
specific transcription in the cultured cell assay, specificity must
reside in this region.
As little as 270bp of 5' flanking DNA is sufficient to direct
tyrosinase expression specifically in cultured cells and in
transgenic animals (54). Comparison of the short regions 5' of
mouse tyrosinase and TRP-1 reveals only a few sequence motifs
present in both. The largest of these is an 1 lbp sequence, with
some palindromic character, AGTCATGTGCT, boxed in
Figure 2. This is the only motif which is also found in the human
tyrosinase gene. The sequence is located between 40 and 140bp
5' of the start of transcription of all three genes. Occurence of
such a sequence by chance is very unlikely, and we suggest that
it has been conserved as a functional element. We propose that
it is a factor-binding element responsible, wholly or partly for
the melanocyte-specific transcription of the tyrosinase and TRP-1.
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